| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BRIEF REPORT |
Departments of Internal Medicine B (M.D., D.M.R., S.B.F.) and Internal Medicine A (H.W.), School of Dentistry (C.S.), and Institute of Epidemiology and Social Medicine (U.J., H.V.), Ernst Moritz Arndt University, D-17487 Greifswald, Germany.
Address all correspondence and requests for reprints to: Dr. Marcus Dörr, Department of Internal Medicine B, Ernst Moritz Arndt University, Friedrich Loeffler Strasse 23a, D-17487 Greifswald, Germany. E-mail: mdoerr{at}uni-greifswald.de.
Background: Elevated plasma fibrinogen levels are associated with an increased risk of cardiovascular events. Decreased serum TSH predicts vascular mortality, which hypothetically could be explained in part by alterations in the blood coagulation system.
Objective: The objective of this study was to investigate the association between thyroid function and plasma fibrinogen levels in a general population.
Design: The population-based Study of Health in Pomerania was performed in a previously iodine-deficient area in Germany, including 4310 subjects, aged 2079 yr. Data for 3804 individuals without thyroid disease were analyzed. Analysis revealed an association between thyroid function status and plasma fibrinogen concentration.
Results: Elevated fibrinogen levels (>3.25 g/liter) were observed in 14 subjects with increased serum TSH levels (32.6%), 973 euthyroid subjects (28.9%), 158 subjects with decreased serum TSH levels (40.7%), and six individuals with overt hyperthyroidism (54.4%). Logistic regression analysis revealed decreased serum TSH as an independent risk factor for elevated fibrinogen levels (odds ratio, 1.42; 95% confidence interval, 1.121.80).
Conclusions: Thyroid function is associated with plasma fibrinogen. Decreased serum TSH is an independent risk factor for elevated plasma fibrinogen levels as a possible explanation for the high cardiovascular mortality among affected subjects.
This article has been cited by other articles:
![]() |
B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Squizzato, E. Romualdi, H. R. Buller, and V. E. A. Gerdes Thyroid Dysfunction and Effects on Coagulation and Fibrinolysis: A Systematic Review J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2415 - 2420. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Volzke, C. Schwahn, H. Wallaschofski, and M. Dorr The Association of Thyroid Dysfunction with All-Cause and Circulatory Mortality: Is There a Causal Relationship? J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2421 - 2429. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Volzke Hyperthyroidism and Mortality J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2228 - 2229. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |